publication venue for
- 44O Updated results from a phase I study evaluating the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC. 9:102273-102273. 2024
- 164P Adjuvant radiation therapy amongst immigrant and Canadian-born/long-term resident women with breast cancer. 8:101504-101504. 2023
- Cancer burden in adolescents and young adults in Europe. 8:100744-100744. 2023
- Corrigendum to ‘Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent’. 7:100614-100614. 2022
- Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆. 6:100092-100092. 2021
- Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports. 5:e000878-e000878. 2020
- Patient and family support in the era of fake e-medicine: food for thought from an international consensus panel. 5:e000696-e000696. 2020
- Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. 4:e000596-e000596. 2019
- Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer. 3:e000302-e000302. 2018
- Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines. 1:e000030-e000030. 2016
- Interventions to improve care coordination between primary healthcare and oncology care providers: a systematic review. 1:e000077-e000077. 2016